Lv1
50 积分 2026-07-25 加入
Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1-Based Immunotherapy
12天前
已完结
Expert Consensus on the Use of Immune Checkpoint Inhibitors in the Liver Transplant Setting: Guidance from the Liver Transplant Committee of the Italian Association for the Study of the Liver (AISF)
15天前
已完结
Corticosteroid therapy for drug-induced liver injury: Mind the gap!
15天前
已完结
Circulating extracellular vesicles carrying PD-1, PD-L1 and CTLA-4 inform resistance to anti-PD-L1-based therapy in HCC
26天前
已完结
Soluble PD‐L1 predicts tumor response and immune‐related adverse events in patients with advanced melanoma treated with anti–PD‐1 antibodies
2个月前
已完结
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab
2个月前
已完结
Immune signature-based uncoupling of checkpoint inhibitor efficacy and toxicity
3个月前
已完结
Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events
3个月前
已完结
New advances in the study of PD-1/PD-L1 inhibitors-induced liver injury
3个月前
已完结
Immunotherapies for hepatocellular carcinoma
3个月前
已完结
皖公网安备34019202002308
